Research Article
Changing Sources of Stigma against Patients with HIV/AIDS in the Rapid Expansion of Antiretroviral Treatment Services in Vietnam
Table 2
Factors associated with the number of stigma types against HIV/AIDS that patients experienced (zero-).
| VARIABLES | Community | Family | Healthcare | HIV disclosure | Coef. | 95%CI | Coef. | 95%CI | Coef. | 95%CI | Coef. | 95%CI |
| Income per capita (vs Poorest) | | | | | | | | | Poor | 0.28 | 0.03; 0.54 | 0.12 | -0.66; 0.90 | 0.73 | -0.28; 1.74 | -0.02 | -0.19; 0.15 | Middle | 0.20 | -0.09; 0.50 | -0.04 | -0.64; 0.57 | -0.25 | -1.22; 0.72 | -0.06 | -0.22; 0.10 | Rich | 0.13 | -0.14; 0.39 | 0.29 | -0.22; 0.80 | 0.58 | -0.48; 1.64 | -0.03 | -0.19; 0.13 | Richest | 0.10 | -0.19; 0.38 | -0.19 | -0.75; 0.37 | -0.45 | -1.52; 0.62 | 0.03 | -0.13; 0.20 | Occupation (vs Unemployed) | | | | | | | | | Free lancer | -0.28 | -0.53; -0.04 | -0.18 | -0.63; 0.28 | -0.10 | -0.82; 0.62 | -0.02 | -0.16; 0.13 | Stable Jobs | -0.42 | -0.70; -0.15 | -0.58 | -1.28; 0.11 | 0.16 | -0.69; 1.02 | -0.05 | -0.22; 0.12 | Other | -0.14 | -0.43; 0.15 | 0.14 | -0.64; 0.92 | -0.52 | -1.46; 0.43 | -0.02 | -0.20; 0.16 | Gender (Male vs Female) | -0.04 | -0.22; 0.15 | -0.13 | -0.55; 0.28 | -0.08 | -0.80; 0.64 | -0.07 | -0.19; 0.05 | Education (>= High school vs < High school) | 0.06 | -0.13; 0.24 | -0.02 | -0.46; 0.42 | -0.30 | -0.96; 0.36 | 0.03 | -0.08; 0.14 | Marital status (vs Single) | | | | | | | | | Live with spouse/partner | 0.16 | -0.11; 0.42 | -0.20 | -1.03; 0.63 | -0.39 | -1.11; 0.33 | 0.01 | -0.15; 0.16 | Widow/Divorce/Separate | 0.16 | -0.16; 0.48 | 0.08 | -0.91; 1.06 | -0.87 | -1.80; 0.06 | 0.15 | -0.04; 0.33 | Ever inject drug (Yes vs No) | 0.04 | -0.14; 0.23 | 0.28 | -1.46; 2.02 | -1.92 | -2.97; -0.87 | 0.09 | -0.01; 0.20 | HIV stage (vs Asymptomatic) | | | | | | | | | Symptomatic | -0.01 | -0.30; 0.28 | 0.69 | 0.03; 1.36 | -0.14 | -1.29; 1.01 | 0.23 | 0.05; 0.41 | AIDS | -0.15 | -0.44; 0.14 | 0.42 | -0.20; 1.03 | -0.06 | -1.00; 0.88 | 0.12 | -0.06; 0.31 | Duration of ART (vs. Not yet) | | | | | | | | | <=1 yr | 0.24 | -0.04; 0.52 | -0.06 | -0.55; 0.42 | -0.12 | -1.12; 0.89 | 0.01 | -0.20; 0.21 | 1; <=2 yr | 0.03 | -0.26; 0.32 | 0.15 | -0.41; 0.70 | -0.40 | -1.56; 0.77 | 0.10 | -0.08; 0.29 | 2; <=4 yr | -0.13 | -0.40; 0.14 | -0.98 | -1.78; -0.17 | -0.90 | -2.04; 0.24 | -0.09 | -0.27; 0.10 | 4; <=7 yr | -0.05 | -0.33; 0.24 | -0.18 | -0.70; 0.33 | -0.95 | -1.99; 0.10 | -0.04 | -0.23; 0.14 | CD4 cell count (<= 200) | | | | | | | | | 200< CD4 <= 350 | 0.12 | -0.10; 0.34 | 0.47 | -1.53; 2.48 | -0.55 | -1.99; 0.89 | 0.00 | -0.12; 0.13 | 350< CD4 <= 500 | -0.04 | -0.31; 0.24 | 0.26 | -1.99; 2.51 | -1.17 | -2.39; 0.05 | -0.07 | -0.22; 0.08 | > 500 | 0.27 | 0.00; 0.55 | 0.56 | -1.62; 2.74 | -0.66 | -1.59; 0.26 | -0.12 | -0.29; 0.06 | Level of health administration (vs Central) | | | | | | | | | Provincial | 0.39 | 0.13; 0.65 | 0.53 | -0.27; 1.32 | 0.77 | -0.91; 2.45 | 0.12 | -0.03; 0.27 | District | 0.35 | 0.09; 0.62 | 0.81 | 0.08; 1.54 | 1.15 | -0.56; 2.86 | 0.22 | 0.06; 0.37 | Constant | 0.37 | -0.11; 0.85 | -1.34 | -3.67; 0.98 | 0.78 | -2.17; 3.74 | 0.05 | -0.26; 0.35 |
|
|
Robust ci in parentheses p<0.01, p<0.05, and p<0.1. |